Continued Breast Cancer Risk Reduction in Postmenopausal Women Treated with Raloxifene: 4-Year Results from the MORE Trial (original) (raw)
References
Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov N, Atkins J, Daly M, Wieand S, Tan-Chiu E, Ford L, Wolmark N: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90: 1371-1388, 1998 Google Scholar
Barakat RR: Tamoxifen and the endometrium. Cancer Treat Res 94: 195-207, 1998 Google Scholar
Cohen FJ, Watts S, Shah A, Akers R, Plouffe L: Uterine effects of three-year raloxifene therapy in postmenopausal women under age 60. Obstet Gynecol 95: 104-110, 2000 Google Scholar
Cummings S, Eckert S, Krueger K, Grady D, Powles T, Cauley J, Norton L, Nickelsen T, Bjarnason N, Morrow M, Lippman M, Black D, Glusman J, Costa A, Jordan VC: The effect of raloxifene on risk of breast cancer in postmenopausal women. JAMA 281: 2189-2197, 1999 Google Scholar
National Institutes of Health, Office of Cancer Communications: Publication of the MORE Trial Results Support Study of Tamoxifen and Raloxifene (STAR). Press Release of National Cancer Institute, 1999
Delmas PD, Bjarnason NH, Mitlak BH, Ravoux A-C, Shah AS, Huster WJ, Draper M, Christiansen C: Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N Engl J Med 337: 1641-1647, 1997 Google Scholar
Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, Christiansen C, Delmas PD, Zanchetta JR, Stakkestad J, Gluer CC, Krueger K, Cohen FJ, Eckert S, Ensrud K, Avioli LV, Lips P, Cummings SR: Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial. JAMA 282: 637-645, 1999 Google Scholar
Walsh BW, Kuller LH, Wild RA, Paul S, Farmer M, Lawrence JB, Shah AS, Anderson PW: Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women. JAMA 279: 1445-1451, 1998 Google Scholar
Barrett-Connor E, Wenger NK, Grady D, Mosca L, Collins P, Kornitzer M, Cox DA, Moscarelli E, Anderson PW: Hormone and nonhormone therapy for the maintenance of postmenopausal health: the need for randomized controlled trials of estrogen and raloxifene. J Womens Health 7: 839-847, 1998 Google Scholar
Veronesi U, Maisonneuve P, Costa A, Sacchini V, Maltoni C, Robertson C, Rotmensz N, Boyle P: Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study. Lancet 352: 93-97, 1998 Google Scholar
Powles T, Eeles R, Ashley S, Easton D, Chang J, Dowsett M, Tidy A, Viggers J, Davey J: Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial. Lancet 352: 98-101, 1998 Google Scholar
Grese TA, Sluka JP, Bryant HU, Cullinan GJ, Glasebrook AL, Jones CD, Matsumoto K, Palkowitz AD, Sato M, Termine JD, Winter MA, Yang NN, Dodge JA: Molecular determinants of tissue selectivity in estrogen receptor modulators. Proceedings of the Natl Acad Sci USA 94: 14105-14110, 1997 Google Scholar
Brzozowski AM, Pike ACW, Dauter Z, Hubbard RE, Bonn T, Engstrom O, Ohman L, Greene GL, Gustafsson JA, Carlquist M: Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389: 753-758, 1997 Google Scholar
Davies G, Huster WJ, Lu Y, Plouffe L, Lakshmanan M: Adverse events reporters by post menopausal women in controlled trials with raloxifene. Obstet Gynecol 93: 558-565, 1999 Google Scholar
Greendale GA, Reboussin BA, Sie A, Singh HR, Olson LK, Gatewood O, Bassett LW, Wasilauskas C, Bush T, Barrett-Connor E: Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Ann Intern Med 130: 262-269, 1999 Google Scholar
Kavanagh AM, Mitchell H, Giles GG: Hormone replacement therapy and accuracy of mammographic screening. Lancet 355: 270-274, 2000 Google Scholar
Freedman M, San Martin J, O'Gorman J, Eckert S, Lippman ME, Lo S-C, Walls EL, Zeng J: Digitized mammography: A clinical trial of post menopausal women randomized to raloxifene, estrogen, or placebo, J Natl Cancer Inst, (In press)
Cauley JA, Lucas FL, Kuller LH, Vogt MT, Browner WS, Cummings SR: Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group. JAMA 276: 1404-1408, 1996 Google Scholar
Zhang Y, Kiel DP, Kreger BE, Cupples LA, Ellison RC, Dorgan JF, Schatzkin A, Levy D, Felson DT: Bone mass and the risk of breast cancer among postmenopausal women. N Engl J Med 336: 611-617, 1997 Google Scholar
Cauley JA, Lucas FL, Kuller LH, Stone K, Browner W, Cummings SR: Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Study of Osteoporotic Fractures Research Group. Ann Intern Med 130: 270-277, 1999 Google Scholar
Ries LAG, Kosary CL, Hankey BF, Miller BA, Clegg L, Edwards BK (eds): SEER Cancer Statistics Review, 1973-1996. National Cancer Institute, Bethesda, MD, 1999 Google Scholar
Cohen FJ, Lu Y: Characterization of hot flashes reported by healthy postmenopausal women receiving raloxifene or placebo during osteoporosis prevention trials. Maturitas 34: 65-73, 2000 Google Scholar
Tomas E, Kauppila A, Blanco G, Apaja-Sarkkinen M, Laatikainen T: Comparison between the effects of tamoxifen and toremifene on the uterus in postmenopausal breast cancer patients. Gynecol Oncol 59: 261-266, 1995 Google Scholar
Dijkhuizen FPHLJ, Brolmann HAM, Oddens BJJ, Roumen RMH, Coebergh JWW, Heintz APM: Transvaginal ultrasonography and endometrial changes in postmenopausal breast cancer patients receiving tamoxifen. Maturitas 25: 45-50, 1996 Google Scholar
Nolvadex (tamoxifen citrate) Package Insert. 1998
Gull B, Karlsson B, Wikland M, Milsom I, Granberg S: Factors influencing the presence of uterine cavity fluid in a random sample of asymptomatic postmenopausal women. Acta Obstet Gynecol Scand 77: 751-757, 1998 Google Scholar
Vuento MH, Pirhonen JP, Makinen JI, Tyrkko JE, Laippala PJ, Gronroos M, Salmi TA: Endometrial fluid accumulation in asymptomatic postmenopausal women. Ultrasound in Obstet Gynecol 8: 37-41, 1996 Google Scholar
Goldstein SR: Postmenopausal endometrial fluid collections revisited: look at the doughnut rather than the hole. Obstet Gynecol 83: 738-740, 1994 Google Scholar
Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E: Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 280: 605-613, 1998 Google Scholar